Hagopian Henry III 4
4 · Annovis Bio, Inc. · Filed Jan 20, 2023
Insider Transaction Report
Form 4
Hagopian Henry III
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-01-18+7,672→ 7,672 totalExercise: $13.17Exp: 2033-01-18→ Common Stock (7,672 underlying)
Footnotes (1)
- [F1]The stock option shall vest in eight consecutive quarterly installments of 1,918 shares each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025.